The U.S. Food and Drug Administration (FDA) approved Comirnaty — the COVID-19 vaccine co-developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) — for use in people aged 16 and older on Monday. The news drove shares of Pfizer and BioNTech up 2.5% and 9.6%, respectively. Fellow vaccine maker Moderna (NASDAQ:MRNA) also saw its stock price surge 7.6%.
So what
The decision marks the first time the FDA has granted full approval for a COVID-19 vaccine. Previously, Pfizer’s and BioNTech’s vaccine was being administered under an emergency....More>>>